5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.60%
Negative revenue growth while UPM.HE stands at 4.69%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-59.67%
Negative gross profit growth while UPM.HE is at 794.20%. Joel Greenblatt would examine cost competitiveness or demand decline.
58.55%
Positive EBIT growth while UPM.HE is negative. John Neff might see a substantial edge in operational management.
58.55%
Positive operating income growth while UPM.HE is negative. John Neff might view this as a competitive edge in operations.
331.94%
Positive net income growth while UPM.HE is negative. John Neff might see a big relative performance advantage.
332.00%
Positive EPS growth while UPM.HE is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
332.00%
Positive diluted EPS growth while UPM.HE is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
279.31%
Positive OCF growth while UPM.HE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
102.76%
Positive FCF growth while UPM.HE is negative. John Neff would see a strong competitive edge in net cash generation.
-30.44%
Negative 10Y revenue/share CAGR while UPM.HE stands at 0.73%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-30.44%
Negative 5Y CAGR while UPM.HE stands at 9.35%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-34.95%
Negative 3Y CAGR while UPM.HE stands at 7.46%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-29.20%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-29.20%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
265.51%
Positive 3Y OCF/share CAGR while UPM.HE is negative. John Neff might see a big short-term edge in operational efficiency.
140.23%
Positive 10Y CAGR while UPM.HE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
140.23%
5Y net income/share CAGR 1.25-1.5x UPM.HE's 112.32%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
227.62%
Positive short-term CAGR while UPM.HE is negative. John Neff would see a clear advantage in near-term profit trajectory.
-18.41%
Negative equity/share CAGR over 10 years while UPM.HE stands at 7.41%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-18.41%
Negative 5Y equity/share growth while UPM.HE is at 19.79%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-22.84%
Negative 3Y equity/share growth while UPM.HE is at 3.13%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-45.38%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
4.43%
We show growth while UPM.HE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-1.77%
Negative asset growth while UPM.HE invests at 1.19%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.04%
BV/share growth above 1.5x UPM.HE's 0.37%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-6.26%
We’re deleveraging while UPM.HE stands at 0.13%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-5.95%
We cut SG&A while UPM.HE invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.